Moens, S., Zhao, P., Baietti, M. F., Marinelli, O., Haver, D. V., Impens, F., . . . Amant, F. (2021). The mitotic checkpoint is a targetable vulnerability of carboplatin-resistant triple negative breast cancers. Nature Portfolio.
Chicago Style (17th ed.) CitationMoens, Stijn, et al. The Mitotic Checkpoint Is a Targetable Vulnerability of Carboplatin-resistant Triple Negative Breast Cancers. Nature Portfolio, 2021.
MLA (8th ed.) CitationMoens, Stijn, et al. The Mitotic Checkpoint Is a Targetable Vulnerability of Carboplatin-resistant Triple Negative Breast Cancers. Nature Portfolio, 2021.
Warning: These citations may not always be 100% accurate.